BioCODE 2-in-1 nano-sensor to determine disease risk in patients.
According to the World Health Organisation, there are at least 4- thousand 500 cancer fatalities and 8 thousand more from cardiovascular disease. These statistics are exacerbated by the circumstances and lack of health care for many of these victims in developing countries. Professor Resia Pretorius, Head of Stellenbosch University's Physiological Sciences Department in the Faculty of Science, and her team of researchers, engineers and scientists, hope to address these needs with the patenting and development of the BioCODE 2-in-1 nano-sensor to determine disease risk in patients. The team is the first recipient of University Technology Funding - UTF. Prof Pretorius starts by explaining what the UTF is..